Clostridioides difficile, formerly known as Clostridium difficile, is a bacterium notorious for causing severe gastrointestinal infections, often in healthcare settings. This resilient pathogen thrives in environments altered by antibiotic use, disrupting the balance of gut microbiota and allowing C. difficile to proliferate and produce toxins. The resulting infection, known as C. difficile-associated disease (CDAD), manifests as diarrhea, abdominal pain, and, in severe cases, life-threatening complications such as pseudomembranous colitis and toxic megacolon. Managing CDAD poses significant challenges due to the bacterium's ability to form resilient spores, making it resistant to many standard disinfection methods. Prevention and control strategies, including stringent hand hygiene practices, judicious antibiotic use, and environmental decontamination, are essential for combating C. difficile infections and reducing their impact on patient outcomes and healthcare systems.
Title : The role of the humoral innate immune system in evasion of streptococcus pyogenes infections
Francis J. Castellino, University of Notre Dame, United States
Title : Global environmental changes and mosquito-borne diseases in coastal areas
Ranjan Ramasamy, IDFISH Technology, United States
Title : The impact of global antibiotic resistance on the healthcare system, public health, environment and society
Reza Nassiri, Michigan State University, United States
Title : Current topics of adult COVID-19, Influenza, and RS virus patients in Japan
Seki Masafumi, Saitama Medical University International Medical Center, Japan
Title : Novel nanotechnology and its potential applications
Stephen Hsu, Augusta University, United States
Title : 2000 years of pandemics: Past, present and future
Claudia Ferreira, Biophytis Sorbonne, France